Crossmark Global Holdings, Inc. Organon & Co. Transaction History
Crossmark Global Holdings, Inc.
- $5.23 Billion
- Q2 2024
A detailed history of Crossmark Global Holdings, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 14,061 shares of OGN stock, worth $264,768. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,061
Previous 14,059
0.01%
Holding current value
$264,768
Previous $264,000
10.23%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding OGN
# of Institutions
795Shares Held
191MCall Options Held
1.59MPut Options Held
931K-
Black Rock Inc. New York, NY32.6MShares$613 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$569 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.1MShares$190 Million0.07% of portfolio
-
State Street Corp Boston, MA9.01MShares$170 Million0.01% of portfolio
-
Nordea Investment Management Ab Stockholm, V77.43MShares$140 Million0.19% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $4.79B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...